ARCHIVES

Gleevec Approval Sets Record For FDA Review: 73 Days

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

ASCO Advises KRAS Testing In Patients With Metastatic Colorectal Cancer

January 30, 2009

In Brief: McIntyre New AACI President, Salmon President Elect; Hubbard NCI AD; Underleider CIB Chief

September 30, 1988

Campath Improves PFS In B-Cell CLL In Phase III Trial

January 26, 2007

Centers Of Excellence In Interventions Aimed at molecular Targets; Approved On 19-6 Vote

July 2, 1999

NCI RFA: Tobacco Use Research Centers

December 18, 1998

NIH Plans Grants For Those Who Barely Miss Payline

April 19, 1991